CLDX vs. LMB
CLDX (Celldex Therapeutics, Inc.) and LMB (Limbach Holdings, Inc.) are both stocks. CLDX operates in Biotechnology (Healthcare), while LMB operates in Engineering & Construction (Industrials). Over the past 10 years, CLDX returned -6.50%/yr vs 23.56%/yr for LMB. At a 0.12 correlation, their price movements are largely independent.
Performance
CLDX vs. LMB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLDX achieves a 23.01% return, which is significantly higher than LMB's 5.02% return. Over the past 10 years, CLDX has underperformed LMB with an annualized return of -6.50%, while LMB has yielded a comparatively higher 23.56% annualized return.
CLDX
- 1D
- 3.02%
- 1M
- 8.72%
- YTD
- 23.01%
- 6M
- 22.52%
- 1Y
- 62.98%
- 3Y*
- -1.99%
- 5Y*
- 2.17%
- 10Y*
- -6.50%
LMB
- 1D
- 2.01%
- 1M
- 14.57%
- YTD
- 5.02%
- 6M
- 1.26%
- 1Y
- -40.69%
- 3Y*
- 54.06%
- 5Y*
- 54.79%
- 10Y*
- 23.56%
CLDX vs. LMB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLDX Celldex Therapeutics, Inc. | 23.01% | 7.48% | -36.28% | -11.02% | 15.35% | 120.55% | 685.65% | -24.88% | -93.03% | -19.77% |
LMB Limbach Holdings, Inc. | 5.02% | -8.99% | 88.12% | 336.79% | 15.67% | -27.01% | 226.19% | 2.72% | -73.39% | -1.91% |
Correlation
The correlation between CLDX and LMB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 21, 2016 | 0.12 |
Fundamentals
CLDX:
$2.22B
LMB:
$986.65M
CLDX:
-$4.27
LMB:
$2.75
CLDX:
2.71K
LMB:
1.52
CLDX:
4.87
LMB:
5.03
CLDX:
$820.00K
LMB:
$652.56M
CLDX:
$805.00K
LMB:
$163.77M
CLDX:
-$216.32M
LMB:
$58.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLDX vs. LMB — Risk / Return Rank
CLDX
LMB
CLDX vs. LMB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and Limbach Holdings, Inc. (LMB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLDX | LMB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.73 | ||
| Sortino ratioReturn per unit of downside risk | +2.50 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.92 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 2.61 | -0.73 | +3.34 |
| Martin ratioReturn relative to average drawdown | 6.76 | -1.03 | +7.79 |
Loading charts...
Drawdowns
CLDX vs. LMB - Drawdown Comparison
The maximum CLDX drawdown since its inception was -99.73%, which is greater than LMB's maximum drawdown of -84.10%. Use the drawdown chart below to compare losses from any high point for CLDX and LMB.
Loading charts...
Drawdown Indicators
| CLDX | LMB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.73% | -84.10% | -15.63% |
Max Drawdown (1Y)Largest decline over 1 year | -24.23% | -55.92% | +31.69% |
Max Drawdown (3Y)Largest decline over 3 years | -70.84% | -55.92% | -14.92% |
Max Drawdown (5Y)Largest decline over 5 years | -73.11% | -55.92% | -17.19% |
Max Drawdown (10Y)Largest decline over 10 years | -97.90% | -84.10% | -13.80% |
Current DrawdownCurrent decline from peak | -94.11% | -45.32% | -48.79% |
Average DrawdownAverage peak-to-trough decline | -78.04% | -31.66% | -46.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.35% | 39.52% | -30.17% |
Volatility
CLDX vs. LMB - Volatility Comparison
The current volatility for Celldex Therapeutics, Inc. (CLDX) is 11.62%, while Limbach Holdings, Inc. (LMB) has a volatility of 16.81%. This indicates that CLDX experiences smaller price fluctuations and is considered to be less risky than LMB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLDX | LMB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.62% | 16.81% | -5.19% |
Volatility (6M)Calculated over the trailing 6-month period | 38.03% | 56.71% | -18.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.82% | 66.31% | -9.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.21% | 62.74% | -3.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.95% | 63.32% | +14.63% |
Dividends
CLDX vs. LMB - Dividend Comparison
Neither CLDX nor LMB has paid dividends to shareholders.
Financials
CLDX vs. LMB - Financials Comparison
This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and Limbach Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLDX and LMB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LMB has higher volatility (16.81%) compared to CLDX (11.62%). In terms of maximum drawdown, CLDX dropped -99.73% vs LMB's -84.10%.
CLDX currently has the higher Sharpe Ratio (1.12 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLDX and LMB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer